Why "Diabetes" Is the Wrong Name
Diabetes mellitus describes glucosuria — an overflow symptom visible only after years of metabolic dysfunction. Energy Storage Disease names the upstream pathophysiology: the four pillars that drive T2DM and can be detected — and reversed — long before the HbA1c threshold.
Cellular Energy Lock (Insulin Resistance)
Peripheral and hepatic insulin resistance impairs glucose uptake. Glucose accumulates as overflow, not because of a glucose problem — because the lock is broken. HOMA-IR quantifies this 10–15 years before HbA1c rises.
Metabolic Inflexibility
Healthy metabolism switches between glucose oxidation (fed) and fatty acid oxidation (fasted). In ESD, this switch is impaired — resulting in impaired fat mobilization, postprandial hyperglycemia, fatigue, and progressive lipid deposition. Measurable by fasting RQ or TG/HDL ratio.
Chronic Energy Surplus Cascade (Twin Cycle)
Caloric overflow exceeds glycogen capacity → visceral fat accumulation → hepatic fat → pancreatic fat. Pancreatic fat drives beta-cell dysfunction. The Twin Cycle Hypothesis (Taylor, 2019) demonstrates this cascade is reversible with sustained energy deficit.
Mitochondrial Dysfunction
Reduced mitochondrial density and oxidative phosphorylation capacity impair substrate utilization. mtDNA copy number and oxidative enzyme activity are reduced in skeletal muscle. Exercise-induced mitochondrial biogenesis is a primary reversal mechanism (Mootha 2003, Kelley 2002).
Ordering an ESD-Aware Panel
Standard metabolic panels miss ESD because they measure overflow, not the underlying resistance. Add these labs to detect ESD early and track reversal.
Standard Panel — Misses ESD
ESD-Aware Panel — Detects Early
Interpreting the Result
| HOMA-IR Score | Interpretation | Typical Stage | Recommended Action |
|---|---|---|---|
| < 1.0 | Optimal insulin sensitivity | Healthy metabolic function | Maintain — repeat in 2–3 yr |
| 1.0 – < 2.0 | Acceptable — normal range | Low-risk | Lifestyle coaching, annual screen |
| 2.0 – < 3.0 | Early insulin resistance | Early ESD — subclinical | Intensive lifestyle; 6-mo recheck |
| 3.0 – < 5.0 | Significant insulin resistance | Significant ESD — pre-diabetes window | Structured dietary intervention + repeat labs |
| ≥ 5.0 | Advanced insulin resistance | ESD advanced — diabetes risk high | Intensive program ± pharmacotherapy + endocrinology |
HOMA-IR = (Fasting insulin [μIU/mL] × Fasting glucose [mg/dL]) ÷ 405. Use molar units for glucose if ordering SI labs: (Glucose [mmol/L] × Insulin [mIU/L]) ÷ 22.5
Reversal Is Real — The Data
These are not pilot studies. These are randomized, peer-reviewed trials demonstrating measurable, durable metabolic remission.
DiRECT Trial — Dietary Intervention
46% of intervention participants achieved HbA1c < 6.5% without medication at 12 months. Weight loss of ≥ 10 kg correlated with 57% remission. The intervention: 825–853 kcal/day formula diet for 3–5 months.
Virta Health 2-Year Study — Nutritional Ketosis
60% of participants reversed T2DM (HbA1c < 6.5% without medication) at 2 years. 94% reduced or eliminated insulin. Mean weight loss 12.8% at year 1. The intervention: continuous nutritional ketosis via individualized low-carbohydrate diet with remote physician monitoring.
Twin Cycle Hypothesis — Ectopic Fat Clearance
Sustained caloric restriction (600 kcal/day) cleared hepatic and pancreatic fat within 8 weeks in T2DM subjects, restoring first-phase insulin secretion and normalizing fasting plasma glucose. Provides mechanistic basis for the ESD reversal model.
Mitochondrial Biogenesis in Reversal
Exercise-induced mitochondrial biogenesis (via PGC-1α activation) restores oxidative phosphorylation capacity in insulin-resistant skeletal muscle. Reduced mtDNA copy number and OXPHOS gene expression are consistently observed in T2DM and prediabetes.
Adding ESD Screening to Your Practice
A practical 5-step workflow for integrating HOMA-IR into routine metabolic screening.
Order Fasting Insulin at Baseline
Add CPT 83525 (fasting insulin) to your next metabolic panel for patients with any of: BMI > 25, NAFLD, PCOS, family history of T2DM, hypertension, acanthosis nigricans, elevated TG, or HDL < 40 (men) / 50 (women).
Calculate HOMA-IR at the Encounter
Use the free HOMA-IR calculator at energystoragedisease.com, or in your EHR: (Fasting insulin × Fasting glucose) ÷ 405. Document as a structured note field. Target < 2.0 for acceptable sensitivity (< 1.0 is optimal).
Stage the Patient Using the ESD Framework
HOMA-IR 2.0–<3.0 = Early ESD; 3.0–<5.0 = Significant ESD; ≥5.0 = Advanced ESD. Scores below 2.0 are Optimal or Acceptable. Frame the diagnosis as Energy Storage Disease — patients understand the storage/overflow model better than abstract glucose thresholds. It increases engagement with lifestyle modification.
Prescribe the ESD Patient App
Direct patients to the free ESD app (iOS + Android). It includes: the HOMA-IR calculator with up to 10-reading trend history (so patients track progress between appointments), a 6-marker lab explainer they can share with lab, the 4-pillar ESD framework, and reversal evidence summaries. No account required; all data stays encrypted on device.
Monitor at 6 Months — Track the Cascade in Reverse
Repeat HOMA-IR + TG/HDL ratio at 6 months. ESD reversal typically follows: TG/HDL improves first (weeks), HOMA-IR improves next (months), then HbA1c (6–18 months). Document the cascade to show patients measurable progress before HbA1c normalizes.
Tools to Share With Patients
Free educational resources — no login required, no patient data collected.
HOMA-IR Calculator
Enter fasting insulin and glucose. Instant HOMA-IR score with interpretation and reversal context.
6 ESD Lab Markers Explained
Simple language guide to each marker — what it measures, what's optimal, and why it matters.
Reversal Evidence Summary
DiRECT, Virta, and Twin Cycle summaries in patient-readable language with trial links.
Printable Provider Fact Sheet
One-page clinical summary of ESD framework, lab panel, and reversal evidence. Print-ready.
Recommend the Free ESD App to Patients
HOMA-IR calculator, 6-marker lab guide, and reversal evidence. No account required. All data stays on the patient's device — HIPAA-safe for your recommendation workflow.
Join the Provider Early Access List
We're building EHR-integrated HOMA-IR tracking, provider dashboards, and a structured ESD reversal program. Join the waitlist to be notified first.
Join the Provider Waitlist
This page is an educational resource. It does not constitute medical advice and does not create a provider–patient relationship.
Clinical decisions should be made in consultation with the patient's full history and current guidelines.
ICD-10 E11 (Type 2 Diabetes Mellitus). HOMA-IR is a validated research tool; clinical thresholds vary by laboratory and population.
Questions or corrections: [email protected]